ClinicalTrials.Veeva

Menu

The Effect of Health Education and Yoga on Menopause Symptoms and Quality of Life According to Pender's Model

E

Eastern Mediterranean University

Status

Not yet enrolling

Conditions

Quality of Life
Menopause Symptoms
Yoga
Health Education

Treatments

Behavioral: health education and yoga intervention group

Study type

Interventional

Funder types

Other

Identifiers

NCT06210412
ETK00-2023-0262

Details and patient eligibility

About

The aim of the study is to examine the effect of health education and yoga intervention prepared according to Pender's Health Promotion Model on menopausal women's "menopause-specific quality of life" compared to routine care. Health education and yoga will be conducted by a certified and responsible investigator. After obtaining informed consent from the participants, the scales will be applied before and after health education and yoga practice.

Full description

It is known that the symptoms experienced by women during menopause affect the woman's quality of life. Many methods have been used in the literature to manage menopause symptoms. However, this study is important to present health education prepared according to Pender's health development model, which will enable women to develop health responsibility awareness, and to manage and alleviate menopausal symptoms of yoga practice planned in this context, to determine its effect on quality of life and to provide a source for literature.

Research hypotheses:

H0= There is no difference between menopause-specific quality of life score averages.

H1= There is a difference between menopause-specific quality of life score averages.

Research question:

1.What are the yoga transformation effect scale scores of the participants in the experimental group after the yoga intervention?

Data Collection Tools Three data collection forms will be used in the research. There is an Introductory Information Form, "Menopause-Specific Quality of Life Scale", and "Yoga Transformation Scale".

Enrollment

66 estimated patients

Sex

Female

Ages

45 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Been in menopause for at least 1 year and at most 5 years
  • Experiencing menopausal symptoms at least 3 to 4 times a week in the last 3 months
  • Those who have no physical disability to practice yoga
  • Able to speak and understand Turkish

Exclusion criteria

  • Those who receive hormone replacement therapy
  • Those who have undergone surgical menopause
  • Having done yoga before

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

66 participants in 2 patient groups

health education and yoga intervention group
Experimental group
Description:
Health education program based on the Penderin Health Promotion Model; It consists of 10 sessions as a program focused on the management of menopause (increasing the quality of life by teaching physical, psychological and social coping methods in menopause, yoga practices and their importance). In the first week, introduction, first tests (Sociodemographic data form, MÖYKÖ), and general introduction of the program will be made. It is a program in which active education methods (question and answer, role play, demonstration, etc.) are used, with each session planned to last approximately 30 minutes. Final tests will be performed at the end of 12 weeks. Yoga practice will be carried out as 45-minute sessions 2 days a week, which will last for 12 weeks, following the health education program.12. At the end of the week, MOQÖ and Yoga Transformation Impact Scale will be applied to those who have completed 10 weeks.
Treatment:
Behavioral: health education and yoga intervention group
Control group
No Intervention group
Description:
Voluntary consent forms, which will be informed during the interview, and a sociodemographic data form, Menopause-Specific Quality of Life Scale, will be filled in by participants who wish to participate in the research. They will then be invited to undergo final testing after 12 weeks.

Trial contacts and locations

1

Loading...

Central trial contact

Meltem Altınışık, 1

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems